GlassScriptPhysician profile
Sam H Hessami
NPI 1831167162
$517.80
in general payments reported to CMS, 2019-2025
7 companies · $86.84 in 2025
The $86.84 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $11.91 · 2022: $15.14 · 2023: $57.41 · 2024: $99.99 · 2025: $86.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.25 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $204.79 | 2019 | |
| Astellas Pharma US INC | $86.90 | 2020-2024 | |
| Femselect INC. | $82.41 | 2023-2024 | Enplace |
| Boston Scientific Corporation | $68.09 | 2022-2025 | Solyx Blue, Bulkamid |
| Abbvie INC. | $33.89 | 2025 | |
| Avanos Medical | $26.79 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Hessami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.